ABBV has been in the news 375% more than usual
Oct 31, 2025, 12:31 AM
-0.18%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: AbbVie (NYSE:ABBV) will announce its quarterly earnings on October 31, 2025, and investors should be aware of key points beforehand. In the broader pharmaceutical industry, Bristol Myers Squibb reported a third-quarter revenue of $12.2 billion, amidst uncertainty regarding the potential of its Alzheimer’s treatment, Cobenfy.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.